Spero Therapeutics Competitors and Similar CompaniesClear all

Spero Therapeutics's competitors and similar companies include EnClear Therapies, CHF Solutions and Respicardia.

	Spero Therapeutics Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections.	EnClear Therapies EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.	CHF Solutions CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.	Respicardia Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
Founding Date	Founding Date 2013	Founding Date 2018	Founding Date 1999	Founding Date 2006
Type	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech healthtech medical devices therapy	Tags Healthcare biotech healthtech medical devices therapy	Tags Healthcare biotech healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy
Locations	Locations Cambridge, US HQ	Locations Newburyport, US HQ	Locations Eden Prairie, US HQ	Locations Hopkins, US HQ
Employees	Employees 5739% increase	Employees 11	Employees 6620% increase	Employees 94
Valuation ($)	Valuation ($) 70.8 m	Valuation ($) N/A	Valuation ($) 34.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $66.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $8.3m (FY, 2025)	Revenue (est.) N/A
Net income	Net income $8.6m (FY, 2025)	Net income N/A	Net income ($17.5m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 121.5m	Total funding raised $ 12m	Total funding raised $ 9m	Total funding raised $ 149.1m